TILT Biotherapeutics raises $10M to push ahead on cancer immunotherapies
TILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportTILT Biotherapeutics (TILT), a clinical-stage Finnish biotech company developing cancer immunotherapies, has completed the first…
While historically lacking in foreign investments, Japan’s biotech scene is thriving with global investors showing…
New Zealand biotech company Amaroq Therapeutics said it is progressing towards clinical trials following a…
Ariceum Therapeutics, a private biotech company developing a radiopharmaceutical product for the diagnosis and systemic…
Dutch biotech company CimCure, which is focusing on the development of vaccine-based cancer immunotherapy, has…
ImmunOs Therapeutics AG, a biopharmaceutical company developing therapeutics for the treatment of cancer and autoimmune…
ANGLE plc has signed a master clinical study agreement with Solaris Health Holdings, LLC and…
U.S. biotech company HotSpot Therapeutics, Inc. is looking to increase its drug development and discovery…
U.S. company CorePath Laboratories is partnering with U.K. diagnostics firm Cizzle Biotechnology on an early-stage…
The UK startup Duke Street Bio has exited stealth mode with funding to develop PARP…
Domain Therapeutics, a biopharmaceutical company in France and Canada developing cancer immunotherapies targeting G protein-coupled…
In just a few years, exosomes have started gaining recognition as a solution to deliver…